Endologix Inc. (NASDAQ:ELGX) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Endologix Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.03 in the quarter versus EPS of $-0.09 in the year-earlier quarter.
Revenue: Rose 33.28% to $34 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Endologix Inc. reported adjusted EPS loss of $0.03 per share. By that measure, the company beat the mean analyst estimate of $-0.06. It beat the average revenue estimate of $33.92 million.
Quoting Management: John McDermott, Endologix President and Chief Executive Officer, said, “Our second quarter revenue was in-line with preliminary results released earlier this month. We continue to generate positive momentum globally with our AFX(NYSE:R) Endovascular AAA System, which was supported by the launch of our U.S. PEVAR training program during the quarter. There has been strong interest in PEVAR from current and new physician customers, who will continue to be trained throughout the year. In Europe, our controlled market release of the Nellix(NYSE:R) EndoVascular Aneurysm Sealing System is tracking to plan, providing us an excellent opportunity to further enhance the procedure and training ahead of a broader commercial launch anticipated in 2014.”
Key Stats (on next page)…
Revenue increased 14.17% from $29.78 million in the previous quarter. EPS decreased to $-0.03 in the quarter versus EPS of $-0.07 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.03 to a loss $0.04. For the current year, the average estimate has moved down from a loss of $0.16 to a loss of $0.19 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)